Neurogene Inc. (NGNE)
NASDAQ: NGNE · Real-Time Price · USD
19.50
-1.58 (-7.50%)
At close: Mar 18, 2026, 4:00 PM EDT
19.89
+0.39 (2.00%)
After-hours: Mar 18, 2026, 5:57 PM EDT
Neurogene Market Cap
Neurogene has a market cap or net worth of $302.05 million as of March 18, 2026. Its market cap has increased by 25.44% in one year.
Market Cap
302.05M
Enterprise Value
46.85M
1-Year Change
25.44%
Ranking
Category
Stock Price
$19.50
Market Cap Chart
Since December 19, 2023, Neurogene's market cap has increased from $193.64M to $302.05M, an increase of 55.99%. That is a compound annual growth rate of 21.91%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 17, 2026 | 326.52M | 2.33% |
| Dec 31, 2025 | 319.09M | -6.03% |
| Dec 31, 2024 | 339.58M | 36.64% |
| Dec 29, 2023 | 248.52M | 28.34% |
| Dec 19, 2023 | 193.64M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Opus Genetics | 341.52M |
| Climb Bio | 340.11M |
| Minerva Neurosciences | 339.70M |
| AC Immune | 337.89M |
| Nautilus Biotechnology | 334.71M |
| NovaBridge Biosciences | 332.04M |
| Forte Biosciences | 331.21M |
| Silence Therapeutics | 326.39M |